# Wuhan Wuyao Pharmaceutical Co., Ltd. – FDA Inspection, May 13, 2016

Source: https://www.keypedia.com/records/fda_inspections/wuhan-wuyao-pharmaceutical-co-ltd/3f868dc4-2481-44cc-85c0-973e69a02356
Source feed: FDA_Inspections

> FDA inspection 972877 of Wuhan Wuyao Pharmaceutical Co., Ltd., May 13, 2016. Classification: Voluntary Action Indicated (VAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 972877
- Company Name: Wuhan Wuyao Pharmaceutical Co., Ltd.
- Inspection Date: 2016-05-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1265191 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/wuhan-wuyao-pharmaceutical-co-ltd/8d0b4058-1567-463d-a6e3-1d5f86da5b6c)
- FDA Inspection 1050824 - 2018-03-09

Company: https://www.keypedia.com/companies/wuhan-wuyao-pharmaceutical-co-ltd/c6378904-e2ab-4e94-84bb-29883d8c497a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c